Stay updated with breaking news from Multi Matrix Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
04.09.2023 - Cosmo Pharmaceuticals N.V. / Key word(s): Agreement Termination of Agreement for Rifamycin SV MMX with Dr. Falk Pharma 04.09.2023 / 05:45 GMT/BST Dublin, Ireland – 4 September 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) ...
Cosmo Pharmaceuticals N.V. / Key word(s): Agreement Cosmo and Adalvo sign License and Supply Agreement for Rifamyc...
04.09.2023 - Cosmo Pharmaceuticals N.V. / Key word(s): Agreement Cosmo and Adalvo sign License and Supply Agreement for Rifamycin SV MMX 200mg in Europe, APAC, MENA and LATAM regions 04.09.2023 / 06:00 GMT/BST Dublin, Ireland – 4 September 2023: Cosmo ... Seite 1
Cosmo Pharmaceuticals N.V. / Key word(s): AgreementTermination of Agreement for Rifamycin SV MMX® with Dr. Falk Pharma 04.09.2023 / 05:45 GMT/BSTDublin, Ireland – 4 September 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the termination by mutual agreement of the license with Dr....
Cosmo Pharmaceuticals N.V. / Key word(s): AgreementCosmo and Adalvo sign License and Supply Agreement for Rifamycin SV MMX® 200mg in Europe, APAC, MENA and LATAM regions 04.09.2023 / 06:00 GMT/BSTDublin, Ireland – 4 September 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Adalvo Ltd. (“Adalvo...